Viridian Therapeutics, Inc.\DE Cash Flow Statement (2014-2026) | VRDN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-17.96M	-14.04M	-28.95M	-25.69M	-29.49M	-28.91M	-45.78M	-68.15M	-55.06M	-47.66M	-66.67M	-48.54M	-64.99M	-76.49M	-79.47M	-86.91M	-100.73M	-35.05M	-118.24M	-111.76M
Share-based Compensation (Quarter)	3.82M	3.98M	3.49M	4.66M	4.88M	4.94M	-14.49M	15.22M	-10.22M	0.69M	61.48M	12.69M	11.77M	8.72M	8.97M	10.22M	10.84M	11.25M	-32.31M	13.39M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)	-0.07M	-0.01M	0.08M					-0.03M	-0.00M		-0.74M			-0.45M	0.94M				0.73M	-0.17M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-14.63M	-11.88M	-16.54M	-21.04M	-18.09M	-20.67M	-34.04M	-61.97M	-45.21M	-38.98M	-38.00M	-45.22M	-46.06M	-67.71M	-73.33M	-92.65M	-75.37M	-84.61M	-23.75M	-119.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.25M	-0.23M	-0.25M	-0.27M	-0.26M	-0.19M	0.94M	2.98M	2.91M	2.54M	3.07M	4.66M	4.41M	3.38M	3.21M	2.32M	1.55M	1.13M	1.75M	1.86M
Amortization of Deferred Charges (Quarter)			0.09M		0.05M	0.05M	0.13M	0.05M	0.05M	0.09M	0.12M	0.12M	0.12M	0.07M	0.06M	0.10M	0.10M	0.10M	2.26M	2.34M
Depreciation & Amortization (CF) (Quarter)	0.03M	0.03M	0.03M	0.04M	0.06M	0.06M	0.14M	0.10M	0.13M	0.14M	0.13M	0.14M	0.14M	0.13M	0.08M	0.12M	0.11M	0.11M	0.12M	0.12M
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Account Payables (Quarter)	-1.11M	1.46M	-1.41M	0.03M	1.70M	8.05M	1.75M	-6.65M	-3.77M	-0.11M	-1.52M	0.48M	0.44M	2.93M	-3.92M	1.76M	4.63M	1.55M	-1.38M	4.63M
Change in Accured Expenses (Quarter)	2.52M	-5.93M	1.63M	0.48M	5.48M	-4.25M	6.00M	2.58M	2.64M	-5.03M	4.53M	-0.89M	7.53M	3.91M	10.79M	-15.83M	6.11M	4.61M	21.32M	-23.69M
Investing Activities
Capital Expenditures (Quarter)	0.12M	0.13M	0.08M	0.18M	0.29M	0.10M	0.23M	0.28M	0.03M	-0.29M	0.87M		0.10M	0.29M	0.11M	0.09M	0.04M	0.13M	0.24M	0.02M
Sales of Property, Plant and Equipment (Quarter)	0.07M	0.00M	0.00M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	-0.50M	24.60M	22.76M	14.23M	14.26M	42.75M	37.70M	64.10M	49.10M	98.49M	102.83M	82.56M	121.34M	144.05M	118.98M	171.39M	131.51M	140.29M	99.01M	168.60M
Cash from Investing Activities (Quarter)	-11.21M	6.25M	-80.21M	8.86M	13.96M	42.65M	-180.60M	-13.29M	40.71M	48.04M	-169.71M	-143.04M	61.98M	-84.67M	-62.91M	100.06M	75.72M	126.08M	-339.42M	77.26M
Financing Activities
Other financing activities (Quarter)	0.22M	5.05M	-5.27M			18.15M	-17.70M				0.51M	10.38M	0.10M	13.65M	-24.13M	0.21M		-0.21M	0.48M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)					-0.45M		0.45M				-15.00M
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)	8.22M	32.40M	32.40M	0.67M	-0.67M	0.18M	24.20M	6.94M	-6.62M	0.26M	109.23M	0.36M	0.69M	1.11M	381.59M	2.30M	-1.74M	9.80M	59.54M
Preferred Shares Issued (Quarter)											76.19M
Misc.
Cash from Financing Activities (Quarter)	7.05M	116.79M	0.17M	0.74M	4.56M	290.93M	26.01M	8.20M	3.07M	15.46M	198.94M	177.08M	0.11M	245.02M	35.52M	9.21M	0.76M	10.86M	405.91M	6.36M
Change in Cash (Quarter)	-18.78M	111.17M	-96.58M	-11.44M	0.43M	312.92M	-188.63M	-67.06M	-1.43M	24.52M	-8.77M	-11.19M	16.03M	92.65M	-100.72M	16.62M	1.11M	52.32M	42.73M	-36.04M
Free Cash Flow (Quarter)	-14.75M	-12.01M	-16.62M	-21.22M	-18.38M	-20.76M	-34.27M	-62.26M	-45.24M	-38.69M	-38.87M	-45.22M	-46.16M	-68.00M	-73.45M	-92.74M	-75.42M	-84.74M	-23.99M	-119.68M
Net Cash Flow (Quarter)	-18.78M	111.17M	-96.58M	-11.44M	0.43M	312.92M	-188.63M	-67.06M	-1.43M	24.52M	-8.77M	-11.19M	16.03M	92.65M	-100.72M	16.62M	1.11M	52.32M	42.73M	-36.04M

Research Tools

Viridian Therapeutics, Inc.\DE Cash Flow Statement (2014-2026) | VRDN

Create an account

Sign In

Reset Password